James F. Young occupies the position of Chairman for Novavax, Inc. and President of MedImmune Oncology, Inc.

He is also on the board of Sagimet Biosciences, Inc. and CannaRoyalty Corp.

Dr. Young previously occupied the position of Chairman for La Jolla Capital, Inc., Chairman, Chief Executive & Financial Officer at Targeted Microwave Solutions, Inc., President-Research & Development at MedImmune LLC, Director-Molecular Genetics Department at Smith Kline & French Laboratories Ltd. and Faculty Member at Icah School of Medicine at Mount Sinai.

James F. Young received a doctorate from Baylor College of Medicine and an undergraduate degree from Villanova University.